News FDA greenlights Roche’s biomarker blood test for Alzheimer's Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.
Patients Why Britain's blood tests are only as reliable as the journe... What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned
R&D Beyond proof of concept: Alzheimer’s and the next chapter of... Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.
News Could Alzheimer's be predicted with a finger-prick test? An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.
Oncology How blood tests can inform cancer treatment decisions, with ... Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.
News Theranos settles with Walgreens – but is left strapped for c... Reported settlement of around $25 million significantly reduces company funds.
News ESC26: Isomab safety evidence on blood vessel growth for CAD Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
